Platelet 3D Preservation Using a Novel Biomimetic Nanofiber Peptide for Reduced Apoptosis and Easy Storage
Source abstract
Abstract
Human platelets (PLTs) are vulnerable to unfavorable conditions, and their adequate supply is limited by strict transportation conditions. We report here that PLTs preserved under three-dimensional (3D) conditions using novel biomimetic nanofiber peptides showed reduced apoptosis compared with classical PLTs stored at 22 °C and facilitated the storage and transportation of PLTs. The mechanism of PLT 3D preservation involves the formation of cross-links and a 3D nanofibrous network by a self-assembled peptide scaffold material at physiological conditions after initiation by triggers in plasma. PLTs adhere to the surface of the nanofibrous network to facilitate the 3D distribution of PLTs. The 3D microstructure, rheological properties, and effect on the inflammatory response and hemolysis were evaluated. Compared to traditional PLTs stored at 22 °C, PLTs subjected to 3D preservation showed similar morphology, number, aggregation activity, and reduced apoptosis. The detection of the reactive oxygen species (ROS) levels demonstrated that both reduced intracellular and mitochondrial ROS levels were correlated with reduced apoptosis. This study reveals a new 3D preservation method for PLTs based on the use of novel biomimetic nanofiber peptides that presents an attractive opportunity for various biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Pancreatic function and diabetes · Surface Modification and Superhydrophobicity
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Health Service and Transfusion Medicine, Academy of Military Medical Sciences, 27(1) Taiping Road, Beijing 100850, China
State Key Laboratory of Food Nutrition and Safety, Tianjin University of Science and Technology, 1038 Dagu South Road, Tianjin 300457, China
Department of Transfusion, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100853, China
Funding
Natural Science Foundation of Beijing Municipality
References (30)
Show source-provided references
1. 10.1002/btpr.160010.1002/btpr.1600 ↗
2. 10.1111/trf.1351110.1111/trf.13511 ↗
3. 10.1016/S0142-9612(03)00340-510.1016/S0142-9612(03)00340-5 ↗
4. 10.1016/j.biomaterials.2017.03.05010.1016/j.biomaterials.2017.03.050 ↗
5. 10.1046/j.1537-2995.1982.22282177116.x10.1046/j.1537-2995.1982.22282177116.x ↗
6. 10.1111/j.1365-2141.1976.tb03587.x10.1111/j.1365-2141.1976.tb03587.x ↗
7. 10.1016/j.thromres.2004.05.01410.1016/j.thromres.2004.05.014 ↗
8. 10.1371/journal.pone.005948210.1371/journal.pone.0059482 ↗
9. 10.1002/adfm.20180850510.1002/adfm.201808505 ↗
10. 10.1021/acsami.8b1922810.1021/acsami.8b19228 ↗
11. 10.1021/acs.biomac.5b0131910.1021/acs.biomac.5b01319 ↗
12. 10.1016/j.exphem.2012.09.00110.1016/j.exphem.2012.09.001 ↗
13. 10.1351/pac20077904071710.1351/pac200779040717 ↗
14. 10.1039/c7nr06528k10.1039/c7nr06528k ↗
15. 10.1002/smll.20200124410.1002/smll.202001244 ↗
16. 10.1002/adfm.20190549310.1002/adfm.201905493 ↗
17. 10.1016/j.bbrc.2017.07.07310.1016/j.bbrc.2017.07.073 ↗
18. 10.1039/c2sm26442k10.1039/c2sm26442k ↗
19. 10.1021/ja102553510.1021/ja1025535 ↗
20. 10.1039/c2sm06927j10.1039/c2sm06927j ↗
21. 10.1002/adma.20160406210.1002/adma.201604062 ↗
22. 10.1111/j.1537-2995.2009.02450.x10.1111/j.1537-2995.2009.02450.x ↗
23. 10.1016/j.addr.2018.03.007.10.1016/j.addr.2018.03.007. ↗
24. 10.1016/j.freeradbiomed.2008.05.00210.1016/j.freeradbiomed.2008.05.002 ↗
25. 10.1523/JNEUROSCI.4468-06.200710.1523/JNEUROSCI.4468-06.2007 ↗
26. 10.1016/S0049-3848(01)00341-310.1016/S0049-3848(01)00341-3 ↗
27. 10.18388/abp.1999_417910.18388/abp.1999_4179 ↗
28. 10.1016/j.jss.2013.05.09710.1016/j.jss.2013.05.097 ↗
29. 10.1182/blood-2010-01-26166910.1182/blood-2010-01-261669 ↗
30. 10.1038/s41591-019-0601-510.1038/s41591-019-0601-5 ↗